Svitlana Demyanets

2.8k total citations
68 papers, 2.2k citations indexed

About

Svitlana Demyanets is a scholar working on Immunology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Svitlana Demyanets has authored 68 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 27 papers in Surgery and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Svitlana Demyanets's work include IL-33, ST2, and ILC Pathways (20 papers), Eosinophilic Esophagitis (16 papers) and Atherosclerosis and Cardiovascular Diseases (8 papers). Svitlana Demyanets is often cited by papers focused on IL-33, ST2, and ILC Pathways (20 papers), Eosinophilic Esophagitis (16 papers) and Atherosclerosis and Cardiovascular Diseases (8 papers). Svitlana Demyanets collaborates with scholars based in Austria, Poland and United Kingdom. Svitlana Demyanets's co-authors include Johann Wojta, Kurt Huber, Christoph Kaun, Gerald Maurer, Ihor Huk, Stefan Stojković, Stefan Pfaffenberger, Sabine Rauscher, Marion Gröger and Walter S. Speidl and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Svitlana Demyanets

65 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Svitlana Demyanets Austria 27 929 639 472 438 296 68 2.2k
Elisabetta Faggin Italy 23 445 0.5× 474 0.7× 574 1.2× 655 1.5× 346 1.2× 56 2.0k
Masashi Sakuma Japan 22 623 0.7× 761 1.2× 860 1.8× 918 2.1× 342 1.2× 128 2.9k
Dimitrios Stakos Greece 27 631 0.7× 286 0.4× 450 1.0× 825 1.9× 316 1.1× 76 2.2k
Mona Skjelland Norway 29 695 0.7× 344 0.5× 804 1.7× 487 1.1× 671 2.3× 67 2.4k
Atsushi Anzai Japan 22 643 0.7× 427 0.7× 828 1.8× 1.0k 2.4× 295 1.0× 52 2.3k
Kirsten Krohg‐Sørensen Norway 24 501 0.5× 365 0.6× 574 1.2× 457 1.0× 539 1.8× 48 1.9k
Natalia López‐Andrés Spain 30 1.1k 1.2× 803 1.3× 911 1.9× 976 2.2× 233 0.8× 99 2.9k
Karen Hamilton United States 18 698 0.8× 465 0.7× 609 1.3× 646 1.5× 160 0.5× 37 2.5k
Lindsey A. MacFarlane United States 21 756 0.8× 467 0.7× 526 1.1× 156 0.4× 334 1.1× 46 2.1k
Kikuo Isoda Japan 31 573 0.6× 751 1.2× 768 1.6× 933 2.1× 524 1.8× 123 2.9k

Countries citing papers authored by Svitlana Demyanets

Since Specialization
Citations

This map shows the geographic impact of Svitlana Demyanets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svitlana Demyanets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svitlana Demyanets more than expected).

Fields of papers citing papers by Svitlana Demyanets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svitlana Demyanets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svitlana Demyanets. The network helps show where Svitlana Demyanets may publish in the future.

Co-authorship network of co-authors of Svitlana Demyanets

This figure shows the co-authorship network connecting the top 25 collaborators of Svitlana Demyanets. A scholar is included among the top collaborators of Svitlana Demyanets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svitlana Demyanets. Svitlana Demyanets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lenz, Max, Robert Zilberszac, Svitlana Demyanets, et al.. (2025). Markers of Hemophagocytic Lymphohistiocytosis Are Associated with Mortality in Critically Ill Patients. Journal of Clinical Medicine. 14(6). 1970–1970.
2.
Kampf, Stephanie, Alexander Micko, Stefan Stojković, et al.. (2022). Elevated EMMPRIN Serum Levels Indicate Plaque Vulnerability in Patients With Asymptomatic High Grade Carotid Stenosis. European Journal of Vascular and Endovascular Surgery. 65(4). 474–483. 5 indexed citations
3.
Theofilatos, Konstantinos, Stefan Stojković, Ferheen Baig, et al.. (2022). A proteomic atlas of atherosclerosis: regional proteomic signatures for plaque inflammation and calcification. Cardiovascular Research. 118(Supplement_1). 4 indexed citations
4.
Laggner, Maria, Alfred Gugerell, Christiane Bachmann, et al.. (2020). Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products. Stem Cell Research & Therapy. 11(1). 9–9. 38 indexed citations
5.
Jabłońska, Agnieszka, Christoph Neumayer, Michael Bolliger, et al.. (2020). Insight into the expression of toll-like receptors 2 and 4 in patients with abdominal aortic aneurysm. Molecular Biology Reports. 47(4). 2685–2692. 6 indexed citations
6.
Demyanets, Svitlana, Alexandra Kaider, Ingrid Simonitsch‐Klupp, et al.. (2020). Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response. Annals of Hematology. 99(11). 2599–2609. 4 indexed citations
7.
Demyanets, Svitlana, Christoph Kaun, Alexandra Kaider, et al.. (2020). The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery. Cardiovascular Diabetology. 19(1). 26–26. 15 indexed citations
8.
Thaler, Barbara, Nagyung Baik, Philipp J. Hohensinner, et al.. (2019). Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage subsets. Blood. 134(6). 561–567. 23 indexed citations
9.
Gugerell, Alfred, Monika Chabicovsky, Maria Laggner, et al.. (2019). Toxicological testing of allogeneic secretome derived from peripheral mononuclear cells (APOSEC): a novel cell-free therapeutic agent in skin disease. Scientific Reports. 9(1). 5598–5598. 16 indexed citations
10.
Rega‐Kaun, Gersina, Christoph Kaun, Barbara Thaler, et al.. (2019). Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery. International Journal of Molecular Sciences. 20(9). 2153–2153. 15 indexed citations
11.
Hohensinner, Philipp J., Christoph Kaun, Matthias Hackl, et al.. (2018). Reduction of Premature Aging Markers After Gastric Bypass Surgery in Morbidly Obese Patients. Obesity Surgery. 28(9). 2804–2810. 35 indexed citations
12.
Kieler, Markus, Matthias Unseld, Johann Wojta, et al.. (2018). Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy. Medical Oncology. 36(1). 1–1. 14 indexed citations
13.
Eilenberg, Wolf, Stefan Stojković, Aleksandra Piechota-Polańczyk, et al.. (2017). Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment. Cardiovascular Diabetology. 16(1). 98–98. 40 indexed citations
14.
Hohensinner, Philipp J., Julia B. Kral‐Pointner, Pavel Uhrín, et al.. (2017). PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent. Arteriosclerosis Thrombosis and Vascular Biology. 37(10). 1913–1922. 29 indexed citations
15.
Krychtiuk, Konstantin A., Stefan Stojković, Max Lenz, et al.. (2017). Predictive value of low interleukin-33 in critically ill patients. Cytokine. 103. 109–113. 24 indexed citations
16.
Stojković, Stefan, Christoph Kaun, Rainer de Martin, et al.. (2016). Interleukin-33 stimulates GM-CSF and M-CSF production by human endothelial cells. Thrombosis and Haemostasis. 116(8). 317–327. 20 indexed citations
17.
Piechota-Polańczyk, Aleksandra, Svitlana Demyanets, Ihor Huk, et al.. (2013). Decreased Tissue Levels of Cyclophilin A, a Cyclosporine A Target and Phospho-ERK1/2 in Simvastatin Patients with Abdominal Aortic Aneurysm. European Journal of Vascular and Endovascular Surgery. 45(6). 682–688. 25 indexed citations
18.
Demyanets, Svitlana, Kurt Huber, & Johann Wojta. (2011). Vascular effects of glycoprotein130 ligands — Part I: Pathophysiological role. Vascular Pharmacology. 56(1-2). 34–46. 20 indexed citations
19.
Demyanets, Svitlana, Stefan Pfaffenberger, Christoph Kaun, et al.. (2006). The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway.. PubMed. 95(1). 107–16. 16 indexed citations
20.
Kaun, Christoph, Gersina Rega‐Kaun, Walter S. Speidl, et al.. (2005). The estrogen metabolite 17β-dihydroequilenin counteracts interleukin-1α induced expression of inflammatory mediators in human endothelial cells in vitro via NF-κB pathway. Thrombosis and Haemostasis. 95(1). 107–116. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026